Tag Archives: Daniel Z. Buchman

Psychedelics, Ethics, and the Commercial Determinants of Health

July 20, 2023 · by · in Global Health, Health Research, Neuroethics, Pharmaceuticals, Science and Technology

Daniel Rosenbaum and Daniel Z. Buchman draw attention to commercial involvement in psychedelic research and to the population health risks associated with this involvement.

The Opioid Epidemic is an Epidemic of Stigma

August 8, 2017 · by · in Death & Assisted Dying, Law & Policy, Pharmaceuticals, Public Health

Kristie Serota and Daniel Z. Buchman argue that eradicating the stigma associated with opioid use is an ethical necessity and is critical for population health.